Logo image of PSNYW

POLESTAR AUTO CLASS C-1 ADS (PSNYW) Stock Price, Quote, News and Overview

NASDAQ:PSNYW - Nasdaq - - Currency: USD

0.205  +0.02 (+8.07%)

After market: 0.217 +0.01 (+5.85%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to PSNYW. PSNYW was compared to 40 industry peers in the Automobiles industry. PSNYW may be in some trouble as it scores bad on both profitability and health. PSNYW is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

PSNYW had negative earnings in the past year.
In the past 5 years PSNYW always reported negative net income.
PSNYW had a negative operating cash flow in each of the past 5 years.
PSNYW Yearly Net Income VS EBIT VS OCF VS FCFPSNYW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -500M -1B -1.5B -2B

1.2 Ratios

With a Return On Assets value of -37.14%, PSNYW is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -37.14%
ROE N/A
ROIC N/A
ROA(3y)-23.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSNYW Yearly ROA, ROE, ROICPSNYW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PSNYW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSNYW Yearly Profit, Operating, Gross MarginsPSNYW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 -100 -150 -200

0

2. Health

2.1 Basic Checks

PSNYW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PSNYW has about the same amount of shares outstanding.
Compared to 1 year ago, PSNYW has a worse debt to assets ratio.
PSNYW Yearly Shares OutstandingPSNYW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500M 1B 1.5B 2B
PSNYW Yearly Total Debt VS Total AssetsPSNYW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.95%
PSNYW Yearly LT Debt VS Equity VS FCFPSNYW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 1B -1B -2B

2.3 Liquidity

A Current Ratio of 0.61 indicates that PSNYW may have some problems paying its short term obligations.
PSNYW has a worse Current ratio (0.61) than 75.00% of its industry peers.
A Quick Ratio of 0.61 indicates that PSNYW may have some problems paying its short term obligations.
The Quick ratio of PSNYW (0.61) is worse than 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
PSNYW Yearly Current Assets VS Current LiabilitesPSNYW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B

5

3. Growth

3.1 Past

PSNYW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -347.20%.
The Revenue for PSNYW has decreased by -22.12% in the past year. This is quite bad
Measured over the past years, PSNYW shows a very strong growth in Revenue. The Revenue has been growing by 57.38% on average per year.
EPS 1Y (TTM)-347.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.29%
Revenue 1Y (TTM)-22.12%
Revenue growth 3Y57.38%
Revenue growth 5YN/A
Sales Q2Q%-16.43%

3.2 Future

PSNYW is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.85% yearly.
PSNYW is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 39.89% yearly.
EPS Next Y-55.18%
EPS Next 2Y-7.68%
EPS Next 3Y1.07%
EPS Next 5Y16.85%
Revenue Next Year-14.1%
Revenue Next 2Y23.4%
Revenue Next 3Y31.96%
Revenue Next 5Y39.89%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PSNYW Yearly Revenue VS EstimatesPSNYW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
PSNYW Yearly EPS VS EstimatesPSNYW Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

PSNYW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PSNYW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNYW Price Earnings VS Forward Price EarningsPSNYW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNYW Per share dataPSNYW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.68%
EPS Next 3Y1.07%

0

5. Dividend

5.1 Amount

No dividends for PSNYW!.
Industry RankSector Rank
Dividend Yield N/A

POLESTAR AUTO CLASS C-1 ADS

NASDAQ:PSNYW (3/7/2025, 8:00:01 PM)

After market: 0.217 +0.01 (+5.85%)

0.205

+0.02 (+8.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)N/A N/A
Inst Owners4.11%
Inst Owner Change-10.04%
Ins Owners62.98%
Ins Owner ChangeN/A
Market Cap432.62M
Analysts46.15
Price Target0.26 (26.83%)
Short Float %0%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.91%
Min EPS beat(2)4.17%
Max EPS beat(2)29.66%
EPS beat(4)3
Avg EPS beat(4)19.61%
Min EPS beat(4)-9.65%
Max EPS beat(4)54.25%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.32%
Min Revenue beat(2)-42.82%
Max Revenue beat(2)-19.82%
Revenue beat(4)0
Avg Revenue beat(4)-25.98%
Min Revenue beat(4)-42.82%
Max Revenue beat(4)-14.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)47.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.76%
EPS NY rev (1m)-8.54%
EPS NY rev (3m)-18.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.11%
Revenue NY rev (1m)-30.26%
Revenue NY rev (3m)-39.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.98
BVpS-0.86
TBVpS-0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.14%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-23.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z N/A
F-ScoreN/A
WACC7.95%
ROIC/WACCN/A
Cap/Depr(3y)341.13%
Cap/Depr(5y)402.63%
Cap/Sales(3y)21.26%
Cap/Sales(5y)82.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-347.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.29%
EPS Next Y-55.18%
EPS Next 2Y-7.68%
EPS Next 3Y1.07%
EPS Next 5Y16.85%
Revenue 1Y (TTM)-22.12%
Revenue growth 3Y57.38%
Revenue growth 5YN/A
Sales Q2Q%-16.43%
Revenue Next Year-14.1%
Revenue Next 2Y23.4%
Revenue Next 3Y31.96%
Revenue Next 5Y39.89%
EBIT growth 1Y-68.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.28%
EBIT Next 3Y29.07%
EBIT Next 5Y23.38%
FCF growth 1Y-36.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.66%
OCF growth 3YN/A
OCF growth 5YN/A